Keisuke Kirita

2.3k total citations
57 papers, 901 citations indexed

About

Keisuke Kirita is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Keisuke Kirita has authored 57 papers receiving a total of 901 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 40 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Keisuke Kirita's work include Lung Cancer Treatments and Mutations (27 papers), Lung Cancer Research Studies (16 papers) and Lung Cancer Diagnosis and Treatment (15 papers). Keisuke Kirita is often cited by papers focused on Lung Cancer Treatments and Mutations (27 papers), Lung Cancer Research Studies (16 papers) and Lung Cancer Diagnosis and Treatment (15 papers). Keisuke Kirita collaborates with scholars based in Japan and United States. Keisuke Kirita's co-authors include Seiji Niho, Kōichi Goto, Shingo Matsumoto, Kiyotaka Yoh, Shigeki Umemura, Hibiki Udagawa, Genichiro Ishii, Masahiro Tsuboi, Yoshitaka Zenke and Hironobu Ohmatsu and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Keisuke Kirita

54 papers receiving 891 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keisuke Kirita Japan 18 567 471 318 109 104 57 901
Kyung Han Nam South Korea 14 428 0.8× 346 0.7× 227 0.7× 86 0.8× 126 1.2× 46 832
Ji Hyun Lee South Korea 12 269 0.5× 232 0.5× 282 0.9× 72 0.7× 54 0.5× 23 609
Xianhua Xu South Korea 12 364 0.6× 502 1.1× 299 0.9× 59 0.5× 69 0.7× 25 795
Ji Zhou China 16 292 0.5× 174 0.4× 129 0.4× 131 1.2× 72 0.7× 39 621
Shinji Fujii Japan 15 356 0.6× 210 0.4× 205 0.6× 73 0.7× 75 0.7× 41 676
Xinqing Lin China 14 421 0.7× 282 0.6× 113 0.4× 54 0.5× 79 0.8× 65 585
F. De Vita Italy 11 405 0.7× 196 0.4× 198 0.6× 47 0.4× 67 0.6× 37 691
Priyanka Iyer United States 14 566 1.0× 159 0.3× 212 0.7× 135 1.2× 128 1.2× 39 1.1k
Nobuyuki Koyama Japan 14 375 0.7× 417 0.9× 265 0.8× 54 0.5× 26 0.3× 48 766

Countries citing papers authored by Keisuke Kirita

Since Specialization
Citations

This map shows the geographic impact of Keisuke Kirita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keisuke Kirita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keisuke Kirita more than expected).

Fields of papers citing papers by Keisuke Kirita

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keisuke Kirita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keisuke Kirita. The network helps show where Keisuke Kirita may publish in the future.

Co-authorship network of co-authors of Keisuke Kirita

This figure shows the co-authorship network connecting the top 25 collaborators of Keisuke Kirita. A scholar is included among the top collaborators of Keisuke Kirita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keisuke Kirita. Keisuke Kirita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kenmotsu, Hirotsugu, Kazushige Wakuda, Keita Mori, et al.. (2022). Randomized Phase 2 Study of Osimertinib Plus Bevacizumab Versus Osimertinib for Untreated Patients With Nonsquamous NSCLC Harboring EGFR Mutations: WJOG9717L Study. Journal of Thoracic Oncology. 17(9). 1098–1108. 90 indexed citations
3.
Sugimoto, Akira, Shigeki Umemura, Tomohiro Miyoshi, et al.. (2021). High proportion of tumor necrosis predicts poor survival in surgically resected high-grade neuroendocrine carcinoma of the lung. Lung Cancer. 157. 1–8. 3 indexed citations
4.
5.
Nakamura, Masaki, Shun‐Ichiro Kageyama, Hibiki Udagawa, et al.. (2020). Differences in failure patterns according to the EGFR mutation status after proton beam therapy for early stage non-small cell lung cancer. Radiotherapy and Oncology. 149. 14–17. 2 indexed citations
6.
7.
Naito, Tomoyuki, Hibiki Udagawa, Keisuke Kirita, et al.. (2019). OA01.05 Cryobiopsy Compared with Forceps Biopsy in Pathological Diagnosis and Biomarker Research in Lung Cancer: A Prospective, Single-Arm Study. Journal of Thoracic Oncology. 14(10). S206–S206. 1 indexed citations
8.
Kirita, Keisuke, Shingo Matsumoto, Y. Ohe, et al.. (2017). Detectability of RET fusions by amplicon-based next generation sequencing in nationwide lung cancer genomic screening project: LC-SCRUM-Japan. Annals of Oncology. 28. v475–v475. 1 indexed citations
9.
Udagawa, Hibiki, Seiji Niho, Keisuke Kirita, et al.. (2017). Impact of denosumab use on the survival of untreated non-squamous non-small cell lung cancer patients with bone metastases. Journal of Cancer Research and Clinical Oncology. 143(6). 1075–1082. 18 indexed citations
10.
Hisakane, Kakeru, Kiyotaka Yoh, Naoki Nakamura, et al.. (2017). Salvage chemoradiotherapy with cisplatin and vinorelbine for postoperative locoregional recurrence of non-small cell lung cancer. Medicine. 96(47). e8635–e8635. 10 indexed citations
11.
Ishibashi, Masayuki, Shinya Neri, Hiroko Hashimoto, et al.. (2017). CD200-positive cancer associated fibroblasts augment the sensitivity of Epidermal Growth Factor Receptor mutation-positive lung adenocarcinomas to EGFR Tyrosine kinase inhibitors. Scientific Reports. 7(1). 46662–46662. 44 indexed citations
12.
Udagawa, Hibiki, Shingo Matsumoto, Kenjiro Imai, et al.. (2016). Association of Serum Anti-GAD Antibody and HLA Haplotypes with Type 1 Diabetes Mellitus Triggered by Nivolumab in Patients with Non–Small Cell Lung Cancer. Journal of Thoracic Oncology. 12(5). e41–e43. 58 indexed citations
13.
Zenke, Yoshitaka, Shigeki Umemura, Eri Sugiyama, et al.. (2016). Successful treatment with afatinib after grade 3 hepatotoxicity induced by both gefitinib and erlotinib in EGFR mutation-positive non-small cell lung cancer. Lung Cancer. 99. 1–3. 11 indexed citations
14.
Zenke, Yoshitaka, Shigeki Umemura, Atsushi Motegi, et al.. (2016). Acute and Progressive Tracheal Stenosis after Proton Beam Therapy with Concurrent Chemotherapy for Non–Small Cell Lung Cancer. Journal of Thoracic Oncology. 11(7). 1181–1183. 1 indexed citations
15.
Kirita, Keisuke, Keiju Aokage, Motohiro Kojima, et al.. (2016). Clinicopathological significance of caveolin-1 expression by cancer-associated fibroblasts in lung adenocarcinoma. Journal of Cancer Research and Clinical Oncology. 143(2). 321–328. 21 indexed citations
16.
Yoh, Kiyotaka, Keisuke Kirita, Shigeki Umemura, et al.. (2015). A retrospective analysis of tolerability in EGFR-mutated NSCLC patients who received afatinib. Annals of Oncology. 26. vii137–vii137.
17.
Watanabe, Naohiro, Seiji Niho, Keisuke Kirita, et al.. (2015). Second-line docetaxel for patients with platinum-refractory advanced non-small cell lung cancer and interstitial pneumonia. Cancer Chemotherapy and Pharmacology. 76(1). 69–74. 31 indexed citations
18.
Saruwatari, Koichi, Shinnosuke Ikemura, Keigo Sekihara, et al.. (2015). Aggressive tumor microenvironment of solid predominant lung adenocarcinoma subtype harboring with epidermal growth factor receptor mutations. Lung Cancer. 91. 7–14. 32 indexed citations
19.
Watanabe, Naohiro, Shigeki Umemura, Seiji Niho, et al.. (2015). Docetaxel for platinum-refractory advanced thymic carcinoma. Japanese Journal of Clinical Oncology. 45(7). 665–669. 8 indexed citations
20.
Kirita, Keisuke, Genichiro Ishii, Yuki Matsumura, et al.. (2013). Identification of Biological Properties of Intralymphatic Tumor Related to the Development of Lymph Node Metastasis in Lung Adenocarcinoma. PLoS ONE. 8(12). e83537–e83537. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kyung Han Nam Breakdown of academic impact, for papers by Ji Hyun Lee Breakdown of academic impact, for papers by Xianhua Xu Breakdown of academic impact, for papers by Ji Zhou Breakdown of academic impact, for papers by Shinji Fujii Breakdown of academic impact, for papers by Xinqing Lin Breakdown of academic impact, for papers by F. De Vita Breakdown of academic impact, for papers by Priyanka Iyer Breakdown of academic impact, for papers by Nobuyuki Koyama
Rankless by CCL
2026